Givaudan Shares Fall on Lower Full-Year Profit
By Nina Kienle
Shares in Givaudan fell after the Swiss company logged lower net profit for 2025 as it continues to tackle a volatile external environment.
In European morning trade, shares were 6.1% lower at 2,946 Swiss francs. Shares are down 6.4% in the year-to-date.
The Swiss manufacturer of flavors, fragrances and active cosmetic ingredients posted net income for the full year of 1.07 billion Swiss francs ($1.39 billion), down from 1.09 billion francs in the prior year. The result came in line with a company-compiled consensus.
Revenue increased 5.1% on a like-for-like basis to 7.47 billion francs, slightly missing the consensus estimate of 7.50 billion francs, according a company-compiled forecast.
Earnings before interest, tax, depreciation and amortization amounted to 1.75 billion, dropping from 1.76 billion the prior year. The margin decreased to 24.2% from 24.5%.
The company said it would propose a cash dividend of 72.00 francs per share, an on-year increase of 2.9%.
"Fiscal 2025 results should provide some relief given pronounced negative sentiment around the sector amid fears of consumer slowdown," Vontobel analyst Arben Hasanaj said in a note to clients.
The company's current valuation is overly negative in light of its potential for value creation, he added.
Write to Nina Kienle at nina.kienle@wsj.com
(END) Dow Jones Newswires
January 29, 2026 06:07 ET (11:07 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
